Products for Research Use Only
RegisterLogin

RECTAS-2.0

CAT: 0804-HY-172552Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-172552Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
RECTAS-2.0 is a small molecule designed to correct RNA mis-splicing caused by the GLA c.639+919G>A mutation, used for the research of Fabry disease[1].
CAS Number
3038234-95-3
UNSPSC
12352005
Target
DNA/RNA Synthesis
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Metabolic Disease
Smiles
ClC1=NC(C(OC[C@H]2CN(C)C(O2)=O)=NC=C3)=C3C(NCC4=CC=CO4)=C1
Molecular Formula
C18H17ClN4O4
Molecular Weight
388.80
References & Citations
[1]Tomonari Awaya, et al. Invention of an oral medication for cardiac Fabry disease caused by RNA mis-splicing. Sci Adv. 2025 Apr 11;11 (15) :eadt9695.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-W110794-01Crystal violet, IND (0.0-2.0)
HY-154918-01LysoPE (18:2/0:0)
HY-118050L589420-0-2
HY-401209-01Synucleozid-2.0
HY-145520-01(±) -2'-hydroxy Ceramide (d18:0/18:0)
HY-175088EOP (t18:0/30:0/18:2)
HY-163165S16:0-19:2-16:0 TG-d5
HY-165657SEOP (t18:0/28:0/18:2) -d11
HY-158878C12 ((±) -2'-Hydroxy) dihydro ceramide (d18:0/12:0)
HY-E70087Taq DNA polymerase 2.0

Alternative Products

CatalogName
GTR19258353-01RECTAS-2.0
bs-83108C-01RECTAS
TBI5273-25MGRECTAS, pre-mRNA splicing modulator
OR22161Tricyclo[3.2.0.0~2,7~]heptane
RRSP525-DLight Green 0.2% in 0.2% Acetic Acid
GTR19240941-01Synucleozid-2.0
T36671C2 Phytoceramide (t18:0/2:0)
1216736Biosan, Rotor Type R-2/0.5/0.2
E4966000010Varispenser 2 - 0.2 - 2 mL
E1151112 Place Rotor For 0.2, 0.5, 1.5 & 2.0 mL - ABDOS

Popular Products